Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exagen (XGN) Capital Leases (2024 - 2026)

Exagen filings provide 3 years of Capital Leases readings, the most recent being $1.8 million for Q1 2026.

  • On a quarterly basis, Capital Leases changed N/A to $1.8 million in Q1 2026 year-over-year; TTM through Mar 2026 was $1.8 million, a N/A change, with the full-year FY2025 number at $2.0 million, up 1148.41% from a year prior.
  • Capital Leases hit $1.8 million in Q1 2026 for Exagen, down from $2.0 million in the prior quarter.
  • In the past five years, Capital Leases ranged from a high of $2.1 million in Q3 2025 to a low of $157000.0 in Q4 2024.
  • Median Capital Leases over the past 3 years was $1.9 million (2025), compared with a mean of $1.5 million.
  • The widest YoY moves for Capital Leases: up 1148.41% in 2025, down 1148.41% in 2025.
  • Exagen's Capital Leases stood at $157000.0 in 2024, then soared by 1148.41% to $2.0 million in 2025, then fell by 8.57% to $1.8 million in 2026.
  • The last three reported values for Capital Leases were $1.8 million (Q1 2026), $2.0 million (Q4 2025), and $2.1 million (Q3 2025) per Business Quant data.